Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Carrega

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Gut Microbes|August 20, 2024
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune responseAlessia Calabrò, Fabiana Drommi, Claudia De Pasquale, et al.
Immunology Letters|December 7, 2016
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanomaIlaria Gandoglia, Federico Ivaldi, Paolo Carrega, et al.
Frontiers in Immunology|January 24, 2022
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint BlockadeCarlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Methods in Cell Biology|May 23, 2026
Analyzing the effect of NK cells on in-vivo models of tumor dissemination by digital pathology and flow cytometryPaola Orecchia, Simonetta Astigiano, Valentina Delli Zotti, et al.
Cancer|January 19, 2008
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cellsPaolo Carrega, Barbara Morandi, Roberta Costa, et al.
International Immunology|March 28, 2009
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCsBarbara Morandi, Lorenzo Mortara, Paolo Carrega, et al.
British Journal of Clinical Pharmacology|June 5, 2020
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system databasePaola Maria Cutroneo, Valentina Isgrò, Valentina Ientile, et al.
Frontiers in Immunology|July 30, 2019
Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor LigandsIrene Bonaccorsi, Domenico Spinelli, Claudia Cantoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2014
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymphPaolo Carrega, Irene Bonaccorsi, Emma Di Carlo, et al.
Blood Advances|January 4, 2018
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cellsAna Raykova, Paolo Carrega, Frank M Lehmann, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Gut Microbes|August 20, 2024
Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune responseAlessia Calabrò, Fabiana Drommi, Claudia De Pasquale, et al.
Immunology Letters|December 7, 2016
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanomaIlaria Gandoglia, Federico Ivaldi, Paolo Carrega, et al.
Frontiers in Immunology|January 24, 2022
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint BlockadeCarlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Methods in Cell Biology|May 23, 2026
Analyzing the effect of NK cells on in-vivo models of tumor dissemination by digital pathology and flow cytometryPaola Orecchia, Simonetta Astigiano, Valentina Delli Zotti, et al.
Cancer|January 19, 2008
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cellsPaolo Carrega, Barbara Morandi, Roberta Costa, et al.
International Immunology|March 28, 2009
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCsBarbara Morandi, Lorenzo Mortara, Paolo Carrega, et al.
British Journal of Clinical Pharmacology|June 5, 2020
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system databasePaola Maria Cutroneo, Valentina Isgrò, Valentina Ientile, et al.
Frontiers in Immunology|July 30, 2019
Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor LigandsIrene Bonaccorsi, Domenico Spinelli, Claudia Cantoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2014
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymphPaolo Carrega, Irene Bonaccorsi, Emma Di Carlo, et al.
Blood Advances|January 4, 2018
Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cellsAna Raykova, Paolo Carrega, Frank M Lehmann, et al.
Pageof 4